EPA/DHA/ALA（オメガ3）のグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global EPA / DHA/ALA (Omega 3) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16149 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

EPA/DHA/ALA（オメガ3）市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のEPA/DHA/ALA（オメガ3）の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界のEPA/DHA/ALA（オメガ3）の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 EPA/DHA/ALA（オメガ3）市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・魚油、藻油 用途別セグメントは次のように区分されます。 ・栄養補助食品、機能性食品・飲料、その他 世界のEPA/DHA/ALA（オメガ3）市場の主要な市場プレーヤーは以下のとおりです。 ・EPAX、Golden Omega、TASA、Omega Protein、Croda、KD Pharma、GC Rieber、Polaris、Auqi 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、EPA/DHA/ALA（オメガ3）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なEPA/DHA/ALA（オメガ3）メーカーの企業概要、2019年～2021年までのEPA/DHA/ALA（オメガ3）の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なEPA/DHA/ALA（オメガ3）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別EPA/DHA/ALA（オメガ3）の販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までのEPA/DHA/ALA（オメガ3）の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域でのEPA/DHA/ALA（オメガ3）市場予測を収録しています。 ・第12、13、14章では、EPA/DHA/ALA（オメガ3）の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：EPAX、Golden Omega、TASA、Omega Protein、Croda、KD Pharma、GC Rieber、Polaris、Auqi ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：魚油、藻油 ・用途別分析2016年-2026年：栄養補助食品、機能性食品・飲料、その他 ・EPA/DHA/ALA（オメガ3）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・EPA/DHA/ALA（オメガ3）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・EPA/DHA/ALA（オメガ3）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・EPA/DHA/ALA（オメガ3）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・EPA/DHA/ALA（オメガ3）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The EPA / DHA/ALA (Omega 3) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global EPA / DHA/ALA (Omega 3) size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global EPA / DHA/ALA (Omega 3) market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
EPA / DHA/ALA (Omega 3) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Fish Oil
Algae Oil

Market segment by Application can be divided into
Dietary Supplements
Functional Foods & Beverages
Others

The key market players for global EPA / DHA/ALA (Omega 3) market are listed below:
EPAX
Golden Omega
TASA
Omega Protein
Croda
KD Pharma
GC Rieber
Polaris
Auqi

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe EPA / DHA/ALA (Omega 3) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of EPA / DHA/ALA (Omega 3), with price, sales, revenue and global market share of EPA / DHA/ALA (Omega 3) in 2018 and 2019.
Chapter 3, the EPA / DHA/ALA (Omega 3) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the EPA / DHA/ALA (Omega 3) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and EPA / DHA/ALA (Omega 3) market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe EPA / DHA/ALA (Omega 3) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 EPA / DHA/ALA (Omega 3) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global EPA / DHA/ALA (Omega 3) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Fish Oil
1.2.3 Algae Oil
1.3 Market Analysis by Application
1.3.1 Overview: Global EPA / DHA/ALA (Omega 3) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Dietary Supplements
1.3.3 Functional Foods & Beverages
1.3.4 Others
1.4 Global EPA / DHA/ALA (Omega 3) Market Size & Forecast
1.4.1 Global EPA / DHA/ALA (Omega 3) Sales in Value (2016-2026))
1.4.2 Global EPA / DHA/ALA (Omega 3) Sales in Volume (2016-2026)
1.4.3 Global EPA / DHA/ALA (Omega 3) Price by Type (2016-2026) & (US$/Unit)
1.5 Global EPA / DHA/ALA (Omega 3) Production Capacity Analysis
1.5.1 Global EPA / DHA/ALA (Omega 3) Total Production Capacity (2016-2026)
1.5.2 Global EPA / DHA/ALA (Omega 3) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 EPA / DHA/ALA (Omega 3) Market Drivers
1.6.2 EPA / DHA/ALA (Omega 3) Market Restraints
1.6.3 EPA / DHA/ALA (Omega 3) Trends Analysis
2 Manufacturers Profiles
2.1 EPAX
2.1.1 EPAX Details
2.1.2 EPAX Major Business
2.1.3 EPAX EPA / DHA/ALA (Omega 3) Product and Services
2.1.4 EPAX EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Golden Omega
2.2.1 Golden Omega Details
2.2.2 Golden Omega Major Business
2.2.3 Golden Omega EPA / DHA/ALA (Omega 3) Product and Services
2.2.4 Golden Omega EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 TASA
2.3.1 TASA Details
2.3.2 TASA Major Business
2.3.3 TASA EPA / DHA/ALA (Omega 3) Product and Services
2.3.4 TASA EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Omega Protein
2.4.1 Omega Protein Details
2.4.2 Omega Protein Major Business
2.4.3 Omega Protein EPA / DHA/ALA (Omega 3) Product and Services
2.4.4 Omega Protein EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Croda
2.5.1 Croda Details
2.5.2 Croda Major Business
2.5.3 Croda EPA / DHA/ALA (Omega 3) Product and Services
2.5.4 Croda EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 KD Pharma
2.6.1 KD Pharma Details
2.6.2 KD Pharma Major Business
2.6.3 KD Pharma EPA / DHA/ALA (Omega 3) Product and Services
2.6.4 KD Pharma EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 GC Rieber
2.7.1 GC Rieber Details
2.7.2 GC Rieber Major Business
2.7.3 GC Rieber EPA / DHA/ALA (Omega 3) Product and Services
2.7.4 GC Rieber EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Polaris
2.8.1 Polaris Details
2.8.2 Polaris Major Business
2.8.3 Polaris EPA / DHA/ALA (Omega 3) Product and Services
2.8.4 Polaris EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Auqi
2.9.1 Auqi Details
2.9.2 Auqi Major Business
2.9.3 Auqi EPA / DHA/ALA (Omega 3) Product and Services
2.9.4 Auqi EPA / DHA/ALA (Omega 3) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 EPA / DHA/ALA (Omega 3) Sales by Manufacturer
3.1 Global EPA / DHA/ALA (Omega 3) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global EPA / DHA/ALA (Omega 3) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in EPA / DHA/ALA (Omega 3)
3.4 Market Concentration Rate
3.4.1 Top 3 EPA / DHA/ALA (Omega 3) Manufacturer Market Share
3.4.2 Top 6 EPA / DHA/ALA (Omega 3) Manufacturer Market Share
3.5 Global EPA / DHA/ALA (Omega 3) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and EPA / DHA/ALA (Omega 3) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global EPA / DHA/ALA (Omega 3) Market Size by Region
4.1.1 Global EPA / DHA/ALA (Omega 3) Sales in Volume by Region (2016-2026)
4.1.2 Global EPA / DHA/ALA (Omega 3) Revenue by Region (2016-2026)
4.2 North America EPA / DHA/ALA (Omega 3) Revenue (2016-2026)
4.3 Europe EPA / DHA/ALA (Omega 3) Revenue (2016-2026)
4.4 Asia-Pacific EPA / DHA/ALA (Omega 3) Revenue (2016-2026)
4.5 South America EPA / DHA/ALA (Omega 3) Revenue (2016-2026)
4.6 Middle East and Africa EPA / DHA/ALA (Omega 3) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global EPA / DHA/ALA (Omega 3) Sales in Volume by Type (2016-2026)
5.2 Global EPA / DHA/ALA (Omega 3) Revenue by Type (2016-2026)
5.3 Global EPA / DHA/ALA (Omega 3) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global EPA / DHA/ALA (Omega 3) Sales in Volume by Application (2016-2026)
6.2 Global EPA / DHA/ALA (Omega 3) Revenue by Application (2016-2026)
6.3 Global EPA / DHA/ALA (Omega 3) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America EPA / DHA/ALA (Omega 3) Sales by Type (2016-2026)
7.2 North America EPA / DHA/ALA (Omega 3) Sales by Application (2016-2026)
7.3 North America EPA / DHA/ALA (Omega 3) Market Size by Country
7.3.1 North America EPA / DHA/ALA (Omega 3) Sales in Volume by Country (2016-2026)
7.3.2 North America EPA / DHA/ALA (Omega 3) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe EPA / DHA/ALA (Omega 3) Sales by Type (2016-2026)
8.2 Europe EPA / DHA/ALA (Omega 3) Sales by Application (2016-2026)
8.3 Europe EPA / DHA/ALA (Omega 3) Market Size by Country
8.3.1 Europe EPA / DHA/ALA (Omega 3) Sales in Volume by Country (2016-2026)
8.3.2 Europe EPA / DHA/ALA (Omega 3) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific EPA / DHA/ALA (Omega 3) Sales by Type (2016-2026)
9.2 Asia-Pacific EPA / DHA/ALA (Omega 3) Sales by Application (2016-2026)
9.3 Asia-Pacific EPA / DHA/ALA (Omega 3) Market Size by Region
9.3.1 Asia-Pacific EPA / DHA/ALA (Omega 3) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific EPA / DHA/ALA (Omega 3) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America EPA / DHA/ALA (Omega 3) Sales by Type (2016-2026)
10.2 South America EPA / DHA/ALA (Omega 3) Sales by Application (2016-2026)
10.3 South America EPA / DHA/ALA (Omega 3) Market Size by Country
10.3.1 South America EPA / DHA/ALA (Omega 3) Sales in Volume by Country (2016-2026)
10.3.2 South America EPA / DHA/ALA (Omega 3) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa EPA / DHA/ALA (Omega 3) Sales by Type (2016-2026)
11.2 Middle East & Africa EPA / DHA/ALA (Omega 3) Sales by Application (2016-2026)
11.3 Middle East & Africa EPA / DHA/ALA (Omega 3) Market Size by Country
11.3.1 Middle East & Africa EPA / DHA/ALA (Omega 3) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa EPA / DHA/ALA (Omega 3) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 EPA / DHA/ALA (Omega 3) Typical Distributors
12.3 EPA / DHA/ALA (Omega 3) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global EPA / DHA/ALA (Omega 3) Revenue by Type, (USD Million), 2021-2026
Table 2. Global EPA / DHA/ALA (Omega 3) Revenue by Application, (USD Million), 2021-2026
Table 3. EPAX Basic Information, Manufacturing Base and Competitors
Table 4. EPAX Major Business
Table 5. EPAX EPA / DHA/ALA (Omega 3) Product and Services
Table 6. EPAX EPA / DHA/ALA (Omega 3) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Golden Omega Basic Information, Manufacturing Base and Competitors
Table 8. Golden Omega Major Business
Table 9. Golden Omega EPA / DHA/ALA (Omega 3) Product and Services
Table 10. Golden Omega EPA / DHA/ALA (Omega 3) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. TASA Basic Information, Manufacturing Base and Competitors
Table 12. TASA Major Business
Table 13. TASA EPA / DHA/ALA (Omega 3) Product and Services
Table 14. TASA EPA / DHA/ALA (Omega 3) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Omega Protein Basic Information, Manufacturing Base and Competitors
Table 16. Omega Protein Major Business
Table 17. Omega Protein EPA / DHA/ALA (Omega 3) Product and Services
Table 18. Omega Protein EPA / DHA/ALA (Omega 3) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Croda Basic Information, Manufacturing Base and Competitors
Table 20. Croda Major Business
Table 21. Croda EPA / DHA/ALA (Omega 3) Product and Services
Table 22. Croda EPA / DHA/ALA (Omega 3) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. KD Pharma Basic Information, Manufacturing Base and Competitors
Table 24. KD Pharma Major Business
Table 25. KD Pharma EPA / DHA/ALA (Omega 3) Product and Services
Table 26. KD Pharma EPA / DHA/ALA (Omega 3) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. GC Rieber Basic Information, Manufacturing Base and Competitors
Table 28. GC Rieber Major Business
Table 29. GC Rieber EPA / DHA/ALA (Omega 3) Product and Services
Table 30. GC Rieber EPA / DHA/ALA (Omega 3) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Polaris Basic Information, Manufacturing Base and Competitors
Table 32. Polaris Major Business
Table 33. Polaris EPA / DHA/ALA (Omega 3) Product and Services
Table 34. Polaris EPA / DHA/ALA (Omega 3) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Auqi Basic Information, Manufacturing Base and Competitors
Table 36. Auqi Major Business
Table 37. Auqi EPA / DHA/ALA (Omega 3) Product and Services
Table 38. Auqi EPA / DHA/ALA (Omega 3) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global EPA / DHA/ALA (Omega 3) Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global EPA / DHA/ALA (Omega 3) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in EPA / DHA/ALA (Omega 3), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global EPA / DHA/ALA (Omega 3) Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and EPA / DHA/ALA (Omega 3) Production Site of Key Manufacturer
Table 44. EPA / DHA/ALA (Omega 3) New Entrant and Capacity Expansion Plans
Table 45. EPA / DHA/ALA (Omega 3) Mergers & Acquisitions in the Past Five Years
Table 46. Global EPA / DHA/ALA (Omega 3) Sales by Region (2016-2021e) & (K Units)
Table 47. Global EPA / DHA/ALA (Omega 3) Sales by Region (2021-2026) & (K Units)
Table 48. Global EPA / DHA/ALA (Omega 3) Revenue by Region (2016-2021e) & (USD Million)
Table 49. Global EPA / DHA/ALA (Omega 3) Revenue by Region (2021-2026) & (USD Million)
Table 50. Global EPA / DHA/ALA (Omega 3) Sales by Type (2016-2021e) & (K Units)
Table 51. Global EPA / DHA/ALA (Omega 3) Sales by Type (2021-2026) & (K Units)
Table 52. Global EPA / DHA/ALA (Omega 3) Revenue by Type (2016-2021e) & (USD Million)
Table 53. Global EPA / DHA/ALA (Omega 3) Revenue by Type (2021-2026) & (USD Million)
Table 54. Global EPA / DHA/ALA (Omega 3) Price by Type (2016-2021e) & (US$/Unit)
Table 55. Global EPA / DHA/ALA (Omega 3) Price by Type (2021-2026) & (US$/Unit)
Table 56. Global EPA / DHA/ALA (Omega 3) Sales by Application (2016-2021e) & (K Units)
Table 57. Global EPA / DHA/ALA (Omega 3) Sales by Application (2021-2026) & (K Units)
Table 58. Global EPA / DHA/ALA (Omega 3) Revenue by Application (2016-2021e) & (USD Million)
Table 59. Global EPA / DHA/ALA (Omega 3) Revenue by Application (2021-2026) & (USD Million)
Table 60. Global EPA / DHA/ALA (Omega 3) Price by Application (2016-2021e) & (US$/Unit)
Table 61. Global EPA / DHA/ALA (Omega 3) Price by Application (2021-2026) & (US$/Unit)
Table 62. North America EPA / DHA/ALA (Omega 3) Sales by Country (2016-2021e) & (K Units)
Table 63. North America EPA / DHA/ALA (Omega 3) Sales by Country (2021-2026) & (K Units)
Table 64. North America EPA / DHA/ALA (Omega 3) Revenue by Country (2016-2021e) & (USD Million)
Table 65. North America EPA / DHA/ALA (Omega 3) Revenue by Country (2021-2026) & (USD Million)
Table 66. North America EPA / DHA/ALA (Omega 3) Sales by Type (2016-2021e) & (K Units)
Table 67. North America EPA / DHA/ALA (Omega 3) Sales by Type (2021-2026) & (K Units)
Table 68. North America EPA / DHA/ALA (Omega 3) Sales by Application (2016-2021e) & (K Units)
Table 69. North America EPA / DHA/ALA (Omega 3) Sales by Application (2021-2026) & (K Units)
Table 70. Europe EPA / DHA/ALA (Omega 3) Sales by Country (2016-2021e) & (K Units)
Table 71. Europe EPA / DHA/ALA (Omega 3) Sales by Country (2021-2026) & (K Units)
Table 72. Europe EPA / DHA/ALA (Omega 3) Revenue by Country (2016-2021e) & (USD Million)
Table 73. Europe EPA / DHA/ALA (Omega 3) Revenue by Country (2021-2026) & (USD Million)
Table 74. Europe EPA / DHA/ALA (Omega 3) Sales by Type (2016-2021e) & (K Units)
Table 75. Europe EPA / DHA/ALA (Omega 3) Sales by Type (2021-2026) & (K Units)
Table 76. Europe EPA / DHA/ALA (Omega 3) Sales by Application (2016-2021e) & (K Units)
Table 77. Europe EPA / DHA/ALA (Omega 3) Sales by Application (2021-2026) & (K Units)
Table 78. Asia-Pacific EPA / DHA/ALA (Omega 3) Sales by Region (2016-2021e) & (K Units)
Table 79. Asia-Pacific EPA / DHA/ALA (Omega 3) Sales by Region (2021-2026) & (K Units)
Table 80. Asia-Pacific EPA / DHA/ALA (Omega 3) Revenue by Region (2016-2021e) & (USD Million)
Table 81. Asia-Pacific EPA / DHA/ALA (Omega 3) Revenue by Region (2021-2026) & (USD Million)
Table 82. Asia-Pacific EPA / DHA/ALA (Omega 3) Sales by Type (2016-2021e) & (K Units)
Table 83. Asia-Pacific EPA / DHA/ALA (Omega 3) Sales by Type (2021-2026) & (K Units)
Table 84. Asia-Pacific EPA / DHA/ALA (Omega 3) Sales by Application (2016-2021e) & (K Units)
Table 85. Asia-Pacific EPA / DHA/ALA (Omega 3) Sales by Application (2021-2026) & (K Units)
Table 86. South America EPA / DHA/ALA (Omega 3) Sales by Country (2016-2021e) & (K Units)
Table 87. South America EPA / DHA/ALA (Omega 3) Sales by Country (2021-2026) & (K Units)
Table 88. South America EPA / DHA/ALA (Omega 3) Revenue by Country (2016-2021e) & (USD Million)
Table 89. South America EPA / DHA/ALA (Omega 3) Revenue by Country (2021-2026) & (USD Million)
Table 90. South America EPA / DHA/ALA (Omega 3) Sales by Type (2016-2021e) & (K Units)
Table 91. South America EPA / DHA/ALA (Omega 3) Sales by Type (2021-2026) & (K Units)
Table 92. South America EPA / DHA/ALA (Omega 3) Sales by Application (2016-2021e) & (K Units)
Table 93. South America EPA / DHA/ALA (Omega 3) Sales by Application (2021-2026) & (K Units)
Table 94. Middle East & Africa EPA / DHA/ALA (Omega 3) Sales by Country (2016-2021e) & (K Units)
Table 95. Middle East & Africa EPA / DHA/ALA (Omega 3) Sales by Country (2021-2026) & (K Units)
Table 96. Middle East & Africa EPA / DHA/ALA (Omega 3) Revenue by Country (2016-2021e) & (USD Million)
Table 97. Middle East & Africa EPA / DHA/ALA (Omega 3) Revenue by Country (2021-2026) & (USD Million)
Table 98. Middle East & Africa EPA / DHA/ALA (Omega 3) Sales by Type (2016-2021e) & (K Units)
Table 99. Middle East & Africa EPA / DHA/ALA (Omega 3) Sales by Type (2021-2026) & (K Units)
Table 100. Middle East & Africa EPA / DHA/ALA (Omega 3) Sales by Application (2016-2021e) & (K Units)
Table 101. Middle East & Africa EPA / DHA/ALA (Omega 3) Sales by Application (2021-2026) & (K Units)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. EPA / DHA/ALA (Omega 3) Typical Distributors
Table 105. EPA / DHA/ALA (Omega 3) Typical Customers
List of Figures
Figure 1. EPA / DHA/ALA (Omega 3) Picture
Figure 2. Global EPA / DHA/ALA (Omega 3) Sales Market Share by Type in 2020
Figure 3. Fish Oil
Figure 4. Algae Oil
Figure 5. Global EPA / DHA/ALA (Omega 3) Sales Market Share by Application in 2020
Figure 6. Dietary Supplements
Figure 7. Functional Foods & Beverages
Figure 8. Others
Figure 9. Global EPA / DHA/ALA (Omega 3) Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global EPA / DHA/ALA (Omega 3) Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global EPA / DHA/ALA (Omega 3) Sales (2016-2026) & (K Units)
Figure 12. Global EPA / DHA/ALA (Omega 3) Price by Type (2016-2026) & (US$/Unit)
Figure 13. Global EPA / DHA/ALA (Omega 3) Production Capacity (2016-2026) & (K Units)
Figure 14. Global EPA / DHA/ALA (Omega 3) Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. EPA / DHA/ALA (Omega 3) Market Drivers
Figure 16. EPA / DHA/ALA (Omega 3) Market Restraints
Figure 17. EPA / DHA/ALA (Omega 3) Market Trends
Figure 18. Global EPA / DHA/ALA (Omega 3) Sales Market Share by Manufacturer in 2020
Figure 19. Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Manufacturer in 2020
Figure 20. EPA / DHA/ALA (Omega 3) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 EPA / DHA/ALA (Omega 3) Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 EPA / DHA/ALA (Omega 3) Manufacturer (Revenue) Market Share in 2020
Figure 23. Global EPA / DHA/ALA (Omega 3) Sales Market Share by Region (2016-2026)
Figure 24. Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Region (2016-2026)
Figure 25. North America EPA / DHA/ALA (Omega 3) Revenue (2016-2026) & (USD Million)
Figure 26. Europe EPA / DHA/ALA (Omega 3) Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific EPA / DHA/ALA (Omega 3) Revenue (2016-2026) & (USD Million)
Figure 28. South America EPA / DHA/ALA (Omega 3) Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa EPA / DHA/ALA (Omega 3) Revenue (2016-2026) & (USD Million)
Figure 30. Global EPA / DHA/ALA (Omega 3) Sales Market Share by Type (2016-2026)
Figure 31. Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Type (2016-2026)
Figure 32. Global EPA / DHA/ALA (Omega 3) Price by Type (2016-2026) & (US$/Unit)
Figure 33. Global EPA / DHA/ALA (Omega 3) Sales Market Share by Application (2016-2026)
Figure 34. Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Application (2016-2026)
Figure 35. Global EPA / DHA/ALA (Omega 3) Price by Application (2016-2026) & (US$/Unit)
Figure 36. North America EPA / DHA/ALA (Omega 3) Sales Market Share by Type (2016-2026)
Figure 37. North America EPA / DHA/ALA (Omega 3) Sales Market Share by Application (2016-2026)
Figure 38. North America EPA / DHA/ALA (Omega 3) Sales Market Share by Country (2016-2026)
Figure 39. North America EPA / DHA/ALA (Omega 3) Revenue Market Share by Country (2016-2026)
Figure 40. United States EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe EPA / DHA/ALA (Omega 3) Sales Market Share by Type (2016-2026)
Figure 44. Europe EPA / DHA/ALA (Omega 3) Sales Market Share by Application (2016-2026)
Figure 45. Europe EPA / DHA/ALA (Omega 3) Sales Market Share by Country (2016-2026)
Figure 46. Europe EPA / DHA/ALA (Omega 3) Revenue Market Share by Country (2016-2026)
Figure 47. Germany EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific EPA / DHA/ALA (Omega 3) Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific EPA / DHA/ALA (Omega 3) Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific EPA / DHA/ALA (Omega 3) Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific EPA / DHA/ALA (Omega 3) Revenue Market Share by Region (2016-2026)
Figure 56. China EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America EPA / DHA/ALA (Omega 3) Sales Market Share by Type (2016-2026)
Figure 63. South America EPA / DHA/ALA (Omega 3) Sales Market Share by Application (2016-2026)
Figure 64. South America EPA / DHA/ALA (Omega 3) Sales Market Share by Country (2016-2026)
Figure 65. South America EPA / DHA/ALA (Omega 3) Revenue Market Share by Country (2016-2026)
Figure 66. Brazil EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa EPA / DHA/ALA (Omega 3) Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa EPA / DHA/ALA (Omega 3) Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa EPA / DHA/ALA (Omega 3) Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa EPA / DHA/ALA (Omega 3) Revenue Market Share by Country (2016-2026)
Figure 72. Turkey EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa EPA / DHA/ALA (Omega 3) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source

---